Showing 121-130 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Targeting sub-micron ultrasound contrast agents to the immune-infiltrated islet microenvironment in Type1 diabetes | Regents of the University of Colorado | Richard Benninger | Cures | 01-July-2024 to 30-June-2027 | $900.000,00 |
| Achieving Health in Emerging Adults with Diabetes Program | Seattle Childrens Hospital | Faisal Malik | Improving Lives | 01-September-2024 to 31-August-2028 | $1.734.029,00 |
| Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes | Penn State College of Medicine | Michael Dennis | Improving Lives | 01-June-2024 to 31-May-2026 | $200.000,00 |
| Determining the role of new genes that may be involved in Type 1 Diabetes Pathogenesis | Beth Israel Deaconess Medical Center Inc | Ismail Syed | Cures | 01-June-2024 to 31-October-2025 | $199.999,67 |
| Investigation of AKS-107 immunotherapeutic in mice and human cells | Vanderbilt University Medical Center (VUMC) | Rachel Bonami | Cures | 01-July-2024 to 30-June-2027 | $800.000,00 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500.000,00 |
| microRNA-146a is a potential therapeutic target for type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2024 to 31-May-2027 | $600.000,00 |
| Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes | University of Miami | Thomas Malek | Cures | 01-June-2024 to 31-May-2027 | $927.000,00 |
| Gaining insight into type 1 diabetes pathogenesis through STAT gain of function | The Regents of the University of California, San Francisco | Martin Thelin | Cures | 01-March-2024 to 28-February-2025 | $110.000,00 |
| Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model | Hugo W. Moser Research Institute at Kennedy Krieger | Karen Dimentstein | Transportfolio | 01-September-2024 to 31-August-2026 | $130.000,00 |